Retirement of Anita Baldauf

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





27 June 2024

Retirement of Anita Baldauf

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Anita Baldauf has
announced her intention not to seek re-election and to retire as a director of the
company at the upcoming shareholders meeting on Friday 2
nd
August 2024.
Chair David Flacks said: “On behalf of the Board, I would like to sincerely thank Anita
for her valuable contribution and service during her four-year tenure. Her industry
knowledge and international finance and marketing experience has been of great
assistance to AFT particularly in its continued growth internationally.”
The Board will now commence a recruitment process for a replacement director, and
further details will be announced in due course.

Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief
Financial Officer.


For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that
develops, markets, and distributes a broad portfolio of pharmaceutical products
across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over the counter, prescription, and hospital.
AFT Pharmaceutical's product portfolio comprises both proprietary and in -licensed
products, and includes patented, branded, and generic drugs.